Email Alert | RSS

北京大学学报（医学版） ›› 2022, Vol. 54 ›› Issue (1): 153-160. doi: 10.19723/j.issn.1671-167X.2022.01.024

• 论著 • 上一篇    下一篇

老年流感肺炎的临床特征及D-二聚体与疾病严重程度的相关性

李佳1,徐钰2,王优雅3,高占成3,△()   

  1. 1.北京大学人民医院急诊科,北京 100044
    2.北京积水潭医院呼吸与危重症医学科,北京 100035
    3.北京大学人民医院呼吸与危重症医学科,北京 100044
  • 收稿日期:2020-07-31 出版日期:2022-02-18 发布日期:2022-02-21
  • 通讯作者: 高占成 E-mail:zcgao@bjmu.edu.cn
  • 基金资助:
    国家科技重大专项艾滋病和病毒性肝炎等重大传染病防治专项(2017ZX10103004)

Clinical characteristics of influenza pneumonia in the elderly and relationship between D-dimer and disease severity

LI Jia1,XU Yu2,WANG You-ya3,GAO Zhan-cheng3,△()   

  1. 1. Department of Emergency, Peking University People’s Hospital, Beijing 100044, China
    2. Department of Pulmonary and Critical Care Medicine, Beijing Jishuitan Hospital, Beijing 100035, China
    3. Department of Pulmonary and Critical Care Medicine, Peking University People’s Hospital, Beijing 100044, China
  • Received:2020-07-31 Online:2022-02-18 Published:2022-02-21
  • Contact: Zhan-cheng GAO E-mail:zcgao@bjmu.edu.cn
  • Supported by:
    National Science and Technology Major Project for Control and Prevention of Major Infectious Diseases of China(2017ZX10103004)

RICH HTML

   

PDF (PC)

摘要：

目的: 研究老年流感肺炎的临床特征以及D-二聚体与流感肺炎严重程度的相关性,以期提高临床医生对此类肺炎的甄别和管理。方法: 回顾性收集2014年起连续5个流感季(当年10月1日至次年3月31日)于北京大学人民医院诊断为流感肺炎的住院患者,年龄>65岁,收集患者的一般资料、临床症状、实验室检查、治疗方式及预后,比较重症和非重症肺炎的临床特点,分析D-二聚体与肺炎严重程度的关系,并应用受试者工作特征(receiver operating characteristic, ROC)曲线评估其预测流感肺炎死亡的效能。结果: 共纳入实验室确诊的老年流感肺炎住院患者52例,男性31例(59.6%),平均年龄(77.1±7.4)岁,符合重症肺炎诊断标准者19例(36.5%),约70%病例出现不同程度发热,重症肺炎组与非重症肺炎组相比,呼吸困难的发生率差异有统计学意义(14/19例,73.7% vs. 10/33例,30.3%,P=0.004),重症肺炎组的CURB-65(confusion, urea, respiratory rate, blood pressure, and age>65)评分、肺炎严重度指数(pneumonia severity index, PSI)评分、C反应蛋白、乳酸脱氢酶、尿素氮、空腹血糖、D-二聚体均高于非重症肺炎组,两组间差异有统计学意义(P值分别为0.004、<0.001、<0.001、0.003、0.038、0.018、<0.001),重症肺炎组的白蛋白则低于非重症肺炎组[(35.8±5.6) g/L vs. (38.9±3.5) g/L, t=-2.348,P=0.018]。入院首次检测的D-二聚体与PSI评分呈显著正相关(r=0.540, 95%CI:0.302~0.714,P<0.001),与氧合指数呈显著负相关(r=-0.559, 95%CI:-0.726-~0.330,P<0.001)。以患者是否住院期间死亡绘制ROC曲线,D-二聚体曲线下面积为0.765(95%CI:0.627~0.872),PSI曲线下面积为0.843(95%CI:0.716~0.929),二者相比,检验效能差异无统计学意义(Z=2.360,P=0.174)。D-二聚体>1 225 μg/L预测流感肺炎住院期间死亡的敏感性为76.92%,特异性为74.36%。结论: 高龄老年流感肺炎患者的发热症状不典型,呼吸困难是重症肺炎的突出表现,D-二聚体升高与老年流感肺炎严重程度相关,D-二聚体>1 200 μg/L对于老年重症流感肺炎住院期间死亡具有较好的预测价值。

关键词: 老年人, 流感, 人, 肺炎, D-二聚体

Abstract:

Objective: To clarify the clinical characteristics of influenza pneumonia in the elderly patients and the relationship between D-dimer and the severity of influenza pneumonia. Methods: In the study, 52 hospitalized patients older than 65 years with confirmed influenza pneumonia diagnosed in Peking University People’s Hospital on 5 consecutive influenza seasons from 2014 were retrospectively analyzed. General information, clinical symptoms, laboratory data, treatment methods and prognosis of the patients were collected. The relationship between D-dimer and pneumonia severity was analyzed, and receiver operating characteristic (ROC) curve was used to evaluate the predictive value of D-dimer. Results: Among the 52 patients, 31 were male (31/52, 59.6%), the average age was (77.1±7.4) years, and 19 of them (36.5%) were diagnosed with severe pneumonia. About 70% patients presenting with fever. In the severe group, the patients were more likely to complain of dyspnea than in the non-severe group (14/19, 73.7% vs. 10/33, 30.3%, P=0.004), severe pneumonia group had higher level of CURB-65 (confusion, urea, respiratory rate, blood pressure, and age>65), pneumonia severity index (PSI), C-reactive protein, urea nitrogen, lactate dehydrogenase, fasting glucose, and D-dimer (P value was 0.004, <0.001, <0.001, 0.003, 0.038, 0.018, and <0.001, respectively), albumin was lower than that in the non-severe group [(35.8±5.6) g/L vs. (38.9±3.5) g/L, t=-2.348, P=0.018]. There was a significant positive correlation between the D-dimer at the first admission and PSI score (r=0.540, 95%CI: 0.302 to 0.714, P<0.001), while a significant negative correlation with PaO2/FiO2 (r=-0.559, 95%CI: -0.726 to -0.330, P<0.001). Area under the curve of D-dimer was 0.765 (95%CI: 0.627 to 0.872). Area under the curve of PSI was 0.843 (95%CI: 0.716 to 0.929). There was no statistically significant difference in test efficacy between the two (Z=2.360, P=0.174). D-dimer level over 1 225 μg/L had a positive predict value for influenza pneumonia in hospital death with a sensitivity of 76.92% and a specificity of 74.36%. Conclusion: Influenza pneumonia in the elderly always has atypical symptoms, dyspnea is a prominent feature in severe cases, D-dimer level is associated with the severity of influenza pneumonia, and greater than 1 200 μg/L has a good predictive value for in-hospital death in the elderly.

Key words: Aged, Influenza, human, Pneumonia, D-dimer

中图分类号: 

  • R563.1

表1

老年流感肺炎患者人口统计学资料和临床表现"

Items Total Severe group Non-severe group Statistical value P
Year
October 1, 2014 to March 31, 2015 7 (13.5) 2 (10.5) 5 (15.2) 1.288 0.863
October 1, 2015 to March 31, 2016 7 (13.5) 2 (10.5) 5 (15.2)
October 1, 2016 to March 31, 2017 6 (11.5) 2 (10.5) 4 (12.1)
October 1, 2017 to March 31, 2018 17 (32.7) 8 (42.1) 9 (27.3)
October 1, 2018 to March 31, 2019 15 (28.8) 5 (26.3) 10 (30.3)
Gender (male) 31 (59.6) 12 (63.2) 19 (57.6) 0.156 0.693
Age/years 77.1±7.4 76.3±7.6 77.5±7.4 -0.544 0.589
65-70 12 (23.1) 5 (26.3) 7 (21.2) 0.360 0.853
71-80 21 (40.4) 8 (42.1) 13 (39.4)
80- 19 (36.5) 6 (31.6) 13 (39.4)
Smoking history 16 (30.8) 5 (26.3) 11 (33.3) 0.279 0.598
Drinking history 6 (11.5) 4 (21.4) 2 (6.1) 2.655 0.103
Coexisting diseases
None 7 (13.5) 2 (10.5) 5 (15.2) 0.298 0.862
1-2 25 (48.1) 9 (47.4) 16 (48.5)
3 and above 20 (38.5) 8 (42.1) 12 (36.4)
Category of coexisting diseases
Coronary heart disease 14 (26.9) 6 (31.6) 8 (24.2) 0.330 0.764
Hypertension 21 (40.4) 8 (42.1) 13 (39.4) 0.037 0.538
Pulmonary diseases 19 (36.5) 7 (36.8) 12 (36.4) 0.001 0.972
Diabetes 15 (28.8) 8 (42.1) 7 (21.2) 2.564 0.126
Chronic renal diseases 5 (9.6) 2 (10.5) 3 (9.1) 0.029 0.610
Chronic liver diseases 6 (11.5) 2 (10.5) 4 (12.1) 0.030 0.620
Cerebrovascular diseases 10 (19.2) 3 (15.8) 7 (21.2) 0.228 0.633
Immune disorders 5 (9.6) 0(0) 5 (15.2) - 0.145
Hematological diseases 10 (19.2) 4 (21.1) 6 (18.2) 0.064 0.800
Cancer 11 (21.2) 4 (21.0) 7 (21.2) 0.020 0.638
Clinical characteristics
Fever 36 (69.2) 13 (68.4) 23 (69.7) 0.009 0.924
Pharyngalgia 14 (26.9) 4 (21.1) 10 (30.3) 0.524 0.543
Cough 29 (55.8) 10 (52.6) 19 (57.6) 0.119 0.730
Expectoration 16 (30.8) 6 (31.6) 10 (30.3) 0.009 0.924
Chest discomfort 16 (30.8) 4 (21.1) 12 (36.4) 0.706 0.401
Dyspnea 24 (46.2) 14 (73.7) 10 (30.3) 1.327 0.004
Hemoptysis 3 (5.8) 0(0) 3 (9.1) - 0.291
Vomiting/diarrhea 7 (13.5) 2 (10.5) 5 (15.2) 0.221 0.638
Myodynia 9 (17.3) 2 (10.5) 7 (21.2) 0.962 0.458
Rigor 4 (7.7) 1 (5.3) 3 (9.1) 0.296 0.543
Fatigue 18 (34.6) 4 (21.1) 14 (42.4) 2.443 0.142
Confusion 7 (13.5) 3 (15.8) 4 (12.1) 0.139 0.697
Vital sign on admission
Temperature/℃ 37.2 (36.5, 38.6) 37.8 (36.9, 39.3) 37.0 (36.5, 38.4) -2.294 0.022
Heart rate/(beat/min) 93.6±18.2 103.7±17.1 87.8±16.4 3.315 0.002
Respiratory rate/(time/min) 20 (18, 22) 22 (20, 24) 18 (18, 20) -1.751 0.080
Systolic blood pressure/mmHg 126 (118, 140) 125 (115, 134) 130 (120, 143) -1.201 0.230
Diastolic blood pressure/mmHg 71 (68, 80) 70 (65, 84) 74 (69, 80) -0.326 0.774
Oxygen saturation/% 93 (91, 94) 92 (90, 93) 93 (92, 95) -2.534 0.011
Score on admission
CURB-65 2.0 (1.0, 3.0) 2.0 (1.0, 2.5) 3.0 (2.0, 4.0) -2.711 0.004
PSI 118 (92, 136) 107 (92, 129) 152 (104, 184) -4.108 <0.001

表2

老年流感肺炎患者入院24 h内辅助检查"

Laboratory data Reference range Severe group Non-severe group Statistical value P
Blood routine
WBC/(×109/L) 3.5-9.5 8.30 (6.83, 14.87) 8.80 (6.50, 11.58) -0.627 0.531
LY/(×109/L) 1.1-3.2 0.60 (0.40, 1.63) 0.92 (0.60, 1.60) -1.407 0.159
Hb/(g/L) 130-175 110.3±29.9 121.2±19.5 -1.600 0.116
PLT/(×109/L) 125-350 156.0 (98.0, 259.0) 179.0 (148.0, 219.5) -1.131 0.258
Biochemistry
AST/(U/L) 9-35 35.0 (16.0, 90.0) 28.0 (17.5, 52.0) -0.875 0.382
ALT/(U/L) 15-40 32.0 (17.0, 61.0) 31.0 (20.5, 57.5) -0.257 0.797
LDH/(U/L) 109-245 285.0 (199.0, 361.0) 176.0 (90.0, 251.0) -2.936 0.003
ALB/(g/L) 40-55 35.8±5.6 38.9±3.5 -2.348 0.018
BUN/(mmol/L) 2.8-7.2 8.8 (5.6, 11.4) 6.0 (4.6, 8.7) -2.072 0.038
CRE/(μmoI/L) 59-104 75.0 (51.0, 88.0) 77.0 (60.5, 89.0) -0.542 0.588
GLU/(mmol/L) 3.3-6.1 6.8 (5.6, 10.4) 5.5 (4.6, 7.0) -2.376 0.018
Aterial blood gas analysis
pH 7.35-7.45 7.47 (7.41, 7.48) 7.44 (7.38, 7.49) -1.276 0.202
PaO2/FiO2/mmHg 400-500 252.4±84.8 333.7±60.9 -4.004 <0.001
PaCO2/mmHg 35-45 35.2±8.5 41.6±10.8 -2.208 0.032
Lac/(mmol/L) <2.5 2.4 (1.8, 3.9) 2.0 (1.0, 3.1) -1.922 0.055
Coagulation function
PT/s 9.4-12.5 11.7 (11.0, 12.8) 12.0 (11.0, 12.9) -2.331 0.200
APTT/s 25.1-36.5 31.4±7.2 30.3±4.5 0.735 0.466
D-dimer/(μg/L) 0-243 908 (627, 1 398) 300 (193, 549) -4.380 <0.001
Inflammatory markers
CRP/(mg/L) 0-10 56.0 (37.8, 78.2) 19.5 (10.5, 37.6) -3.706 <0.001
PCT/(μg/L) <0.01 0.88 (0.16, 1.83) 0.22 (0.12, 0.99) -1.730 0.084
Myocardial injury markers
TnI greater than 2 fold 3/17 (17.6) 3/28 (10.7) 0.440 0.507
BNP greater than 2 fold 4/15 (26.7) 3/28 (10.7) 1.824 0.215

表3

老年流感肺炎患者诊治经过、并发症和转归"

Items Total Severe group Non-severe group Statistical value P
Onset to admission/d 7.0 (2.3, 8.0) 7.0 (5.0, 9.0) 7.0 (2.5, 9.0) -0.459 0.646
Virus type 0.847 0.838
A/H1N1 17 (32.7) 7 (36.8) 10 (30.3)
A/H3N2 17 (32.7) 5 (26.3) 12 (36.4)
B 14 (26.9) 5 (26.3) 9 (27.3)
Mixed 4 (7.7) 2 (10.5) 2 (6.1)
Onset to antiviral treatment 0.239 0.135
≤48 h 13 (25.0) 7 (36.8) 6 (18.2)
>48 h 39 (75.0) 12 (63.3) 27 (81.8)
Antiviral drug 9.257 0.010
Oseltamivir 45 (86.5) 13 (68.4) 32 (97.0)
Oseltamivir plus Peramivir 4 (7.7) 4 (21.1) 0(0)
Unused 3 (5.8) 2 (10.5) 1 (3.0)
Co-infection
Bacterial 13 (25.0) 9 (47.4) 4 (12.1) 7.989 0.008
Fungus 3 (5.8) 2 (10.5) 1 (3.0) 0.249 0.618
Antibiotics before admission 45 (86.5) 16 (84.2) 29 (87.9) 0.139 0.709
Antibiotic during admission 0.368 0.947
Unused 3 (5.8) 1 (5.2) 2 (6.1)
1 19 (36.5) 7 (36.8) 12 (36.4)
2 26 (50.0) 9 (47.4) 17 (51.5)
≥3 4 (7.7) 2 (10.5) 2 (6.1)
Antifungal 6 (11.5) 3 (15.8) 3 (9.1) 0.530 0.467
Hormonotherapy 23 (44.2) 12 (63.2) 11 (33.3) 4.348 0.037
Respiratory support
Nasal catheter oxygen 48 (92.3) 19 (100.0) 29 (87.9) 2.495 0.114
Mask oxygen 10 (19.2) 3 (15.8) 7 (21.1) 0.228 0.633
Noninvasive ventilation 23 (44.2) 10 (52.6) 13 (39.4) 0.857 0.355
Invasive ventilation 9 (17.3) 9 (47.4) 0(0) - <0.001
Other support modes
CRRT 9 (17.3) 4 (21.1) 5 (15.2) 0.026 0.588
ECMO 3 (5.8) 3 (15.8) 0(0) - 0.044
Complications
ARDS 16 (30.8) 10 (52.6) 6 (18.2) 6.718 0.010
Pneumothorax 4 (7.7) 2 (10.5) 2 (6.1) 0.339 0.561
Shock 9 (17.3) 6 (31.6) 3 (9.1) 2.843 0.092
Acute kidney injury 12 (23.1) 6 (31.6) 6 (18.2) 1.219 0.270
Myocardial injury 6 (11.5) 3 (15.8) 3 (9.1) 0.077 0.782
Liver injury 9 (17.3) 5 (26.3) 4 (12.1) 1.697 0.193
DIC 10 (19.2) 7 (36.8) 3 (9.1) 4.325 0.038
Encephalopathy 3 (5.8) 2 (10.5) 1 (3.0) 0.249 0.618
ICU admission 20 (38.5) 12 (63.2) 8 (24.2) 7.715 0.005
Length of stay/d 13.5 (9.0, 20.0) 14.0 (11.0, 20.0) 10.0 (8.5, 20.0) -1.162 0.245
Death 13 (25.0) 9 (47.4) 4 (12.1) 7.989 0.008

图1

D-二聚体与PSI和PaO2/FiO2的关系"

图2

D-二聚体和PSI预测住院期间死亡的受试者工作特征曲线"

[1] Luliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study[J]. Lancet, 2018, 391(10127):1285-1300.
doi: 10.1016/S0140-6736(17)33293-2
[2] Gefenaite G, Pistol A, Popescu R, et al. Estimating burden of influenza-associated influenza-like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12-2015/16 influenza seasons[J]. Influenza Other Respir Viruses, 2018, 12(1):183-192.
doi: 10.1111/irv.2018.12.issue-1
[3] Loubet P, Samihlenzi N, Galtier F, et al. Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study[J]. J Clin Virol, 2016, 79:68-73.
doi: S1386-6532(16)30069-5 pmid: 27105315
[4] 中华人民共和国国家健康委员会. 流行性感冒诊疗方案(2018年版修订版)[J]. 中华临床感染病杂志, 2019, 12(1):1-5.
[5] 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(4):253-279.
[6] 中华医学会血液学分会血栓与止血学组. 弥散性血管内凝血诊断中国专家共识(2017年版)[J]. 中华血液学杂志, 2017, 38(5):361-363.
[7] Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J]. Am J Kindney Dis, 2013, 61(5):649-672.
[8] Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008, 36(1):296-327.
pmid: 18158437
[9] Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: Advances in diagnosis and treatment[J]. JAMA, 2018, 319(7):698-710.
doi: 10.1001/jama.2017.21907
[10] Childs A, Zullo AR, Joyce NR, et al. The burden of respiratory infections among older adults in long-term care: A systematic review[J]. BMC Geriatr, 2019, 19(1):210.
doi: 10.1186/s12877-019-1236-6
[11] Chow EJ, Doyle JD, Uyeki TM. Influenza virus-related critical illness: prevention, diagnosis, treatment[J]. Crit Care, 2019, 23(1):214.
doi: 10.1186/s13054-019-2491-9
[12] Czaja CA, Miller L, Alden N, et al. Age-related differences in hospitalization rates, clinical presentation, outcomes among older adults hospitalized with influenza: U.S. Influenza Hospitalization Surveillance Network(FluSurv-NET)[J]. Open Forum Infect Dis, 2019, 6(7): ofz225.
[13] Matsuno O, Kataoka H, Takenaka R, et al. Influence of age on symptoms and laboratory findings at presentation in patients with influenza-associated pneumonia[J]. Arch Gerontol Geriatr, 2009, 49(2):322-325.
doi: 10.1016/j.archger.2008.11.015
[14] Talbot HK. Influenza in older adults[J]. Infect Dis Clin North Am, 2017, 31(4):757-766.
doi: 10.1016/j.idc.2017.07.005
[15] Aronen M, Viikari L, Kohonen I, et al. Respiratory tract virus infections in the elderly with pneumonia[J]. BMC Geriatrics, 2019, 19(1):111.
doi: 10.1186/s12877-019-1125-z pmid: 30991957
[16] Chung JY, Hsu CC, Chen JH, et al. Shock index predicted mortality in geriatric patients with influenza in the emergency department[J]. Am J Emerg Med, 2019, 37(3):391-394.
doi: 10.1016/j.ajem.2018.05.059
[17] van Asten L, Luna Pinzon A, de Lange DW, et al. Estimating severity of influenza epidemics from severe acute respiratory infections (SARI) in intensive care units[J]. Crit Care, 2018, 22(1):351.
doi: 10.1186/s13054-018-2274-8
[18] Zhou F, Li H, Gu L, et al. Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients[J]. Resp Med, 2018, 134:86-91.
doi: 10.1016/j.rmed.2017.11.017
[19] Sahuquillo JM, Menéndez R, Méndez R, et al. Age-related risk factors for bacterial aetiology in community-acquired pneumonia[J]. Respirology, 2016, 21(8):1472-1479.
doi: 10.1111/resp.12851 pmid: 27417291
[20] Daoud A, Laktineh A, Macrander C, et al. Pulmonary complications of influenza infection: A targeted narrative review[J]. Postgrad Med, 2019, 131(5):299-308.
doi: 10.1080/00325481.2019.1592400 pmid: 30845866
[21] Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortality[J]. JAMA Cardiol, 2016, 1(3):274-281.
doi: 10.1001/jamacardio.2016.0433
[22] Kilic H, Kanbay A, Karalezli A, et al. Clinical characteristics of 75 pandemic H1N1 influenza patients from Turkey; risk factors for fatality[J]. Turk J Med Sci, 2015, 45(3):562-567.
doi: 10.3906/sag-1401-111
[23] Ma S, Lai X, Chen Z, et al. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China[J]. Int J Infect Dis, 2020, 96(1):683-687.
doi: 10.1016/j.ijid.2020.05.068
[24] Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19[J]. J Thromb Haemost, 2020, 18(6):1324-1329.
doi: 10.1111/jth.v18.6
[25] Wang ZF, Su F, Lin XJ, et al. Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1)[J]. Thromb Res, 2011, 127(3):198-201.
doi: 10.1016/j.thromres.2010.11.032 pmid: 21216444
[26] Kim MA, Park JS, Lee CW, et al. Pneumonia severity index in viral community acquired pneumonia in adults[J]. PLoS One, 2019, 14(3):e0210102.
doi: 10.1371/journal.pone.0210102
[27] Dominguez-Cherit G, De la Torre A, Rishu A, et al. Influenza A(H1N1pdm09)-related critical illness and mortality in Mexico and Canada, 2014[J]. Crit Care Med, 2016, 44(10):1861-1870.
doi: 10.1097/CCM.0000000000001830 pmid: 27359085
[1] 任明辉, 王敏敏. 新形势下中国全球卫生学科发展的再思考与建议[J]. 北京大学学报（医学版）, 2024, 56(5): 751-755.
[2] 刘园梅, 傅义程, 郝靖欣, 张福春, 刘慧琳. 老年髋部骨折患者住院期间发生术后心力衰竭的列线图预测模型的构建及验证[J]. 北京大学学报（医学版）, 2024, 56(5): 874-883.
[3] 刘家骏, 刘国康, 朱玉虎. 免疫相关性重症肺炎1例[J]. 北京大学学报（医学版）, 2024, 56(5): 932-937.
[4] 张树栋,谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报（医学版）, 2024, 56(4): 562-564.
[5] 应沂岑,杜毅聪,李志华,张一鸣,李新飞,王冰,张鹏,朱宏建,周利群,杨昆霖,李学松. 机器人辅助腹腔镜下颊黏膜补片输尿管成形术治疗复杂输尿管狭窄[J]. 北京大学学报（医学版）, 2024, 56(4): 640-645.
[6] 张浩宇,石逸雯,潘薇,刘爱萍,孙昕霙,李曼,张旭熙. 基于不同失能水平的老年人照料需求的影响因素[J]. 北京大学学报（医学版）, 2024, 56(3): 431-440.
[7] 靖婷,江华,李婷,申倩倩,叶兰,曾银丹,梁文欣,冯罡,司徒文佑,张玉梅. 中国西部5城市中老年人血清25羟基维生素D与握力的相关性[J]. 北京大学学报（医学版）, 2024, 56(3): 448-455.
[8] 林郁婷,王华丽,田宇,巩俐彤,常春. 北京市老年人认知功能的影响因素[J]. 北京大学学报（医学版）, 2024, 56(3): 456-461.
[9] 费秀文,刘斯,汪波,董爱梅. 成人及儿童组织坏死性淋巴结炎临床特征及治疗[J]. 北京大学学报（医学版）, 2024, 56(3): 533-540.
[10] 刘笑晗,杨帆,王昕迪,黄宁,程陶朱,郭静. 中国流动人口自评健康状况影响因素及公平性[J]. 北京大学学报（医学版）, 2024, 56(2): 223-229.
[11] 汤华萌,袁典琪,王明星,杨晗冰,郭超. 数字融入和健康生活方式对社会经济状况与老年人抑郁关系的序列中介作用[J]. 北京大学学报（医学版）, 2024, 56(2): 230-238.
[12] 吴一凡,玉应香,谢岚,张志达,常翠青. 不同体重指数青年男性的静息能量消耗特点及预测方程评价[J]. 北京大学学报（医学版）, 2024, 56(2): 247-252.
[13] 朱金荣,赵亚娜,黄巍,赵微微,王悦,王松,苏春燕. 感染新型冠状病毒的血液透析患者的临床特征[J]. 北京大学学报（医学版）, 2024, 56(2): 267-272.
[14] 胡攀攀,李彦,刘啸,唐彦超,李梓赫,刘忠军. 自稳式人工椎体在颈椎前路手术中的应用[J]. 北京大学学报（医学版）, 2024, 56(1): 161-166.
[15] 潘媛,顾航,肖涵,赵笠君,汤祎熳,葛雯姝. 泛素特异性蛋白酶42调节人脂肪干细胞成骨向分化[J]. 北京大学学报（医学版）, 2024, 56(1): 9-16.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部